After IM Team 1 & 2 is Xeljanz next one to be eliminated









Derm is run by clowns who have failed for the past 5 years with one product. With a tainted class of JAKs, good luck to the nightmare of selling products with such baggage.
 
























Xeljanz is next to get dissolved, be lucky if only 60% cut.
Entire division gone by April and career Mr Doom Gladstone is hand placing his own Ax Person who has experience w layoffs and bloodbath.

If you get a job offer with 10% pay by Jan, tale it aa Jan 1st Pfizer is changing severance to only 1 wk for each year. No lump sum, just keep on payroll for those weeks so they can take out the new Obama taxes & increase healthcare for covid.
your already a dollar late dollar short
 




Xeljanz is next to get dissolved, be lucky if only 60% cut.
Entire division gone by April and career Mr Doom Gladstone is hand placing his own Ax Person who has experience w layoffs and bloodbath.

If you get a job offer with 10% pay by Jan, tale it aa Jan 1st Pfizer is changing severance to only 1 wk for each year. No lump sum, just keep on payroll for those weeks so they can take out the new Obama taxes & increase healthcare for covid.
your already a dollar late dollar short
The enhanced severance is through the end of 2022.
 




Xeljanz is next to get dissolved, be lucky if only 60% cut.
Entire division gone by April and career Mr Doom Gladstone is hand placing his own Ax Person who has experience w layoffs and bloodbath.

If you get a job offer with 10% pay by Jan, tale it aa Jan 1st Pfizer is changing severance to only 1 wk for each year. No lump sum, just keep on payroll for those weeks so they can take out the new Obama taxes & increase healthcare for covid.
your already a dollar late dollar short
All should be gone but they will just go back to the 120 reps solo territories & 12 DMs that they had pre GI screw up double expansion.
 




Multiple black eyes to PFE- no to broad based 3rd Covid doses and then overseas..
CHMP takes negative opinion on Pfizer's tanezumab for osteoarthritis pain
Sep. 17, 2021




medium_image_1282428700.jpg

stefanamer/iStock via Getty Images


  • The European Medicine Agency's Committee for Medicinal Products for Human Use ("CHMP") has issued a negative opinion on Pfizer's (PFE-1.1%) Raylumis (tanezumab) for pasin associated with osteoarthritis.
  • CHMP said although tanezumab demonstrated pain relief and improved physical functioning compared with placebo, the difference was small.
 
















All should be gone but they will just go back to the 120 reps solo territories & 12 DMs that they had pre GI screw up double expansion.
There never were solo territories-they were mirrored. The big mistake was the GI expansion (how much revenue has come from GI?) and then again another GI specialist in each district. Some bold move, huh? The person making these decisions is now gone.